HPC
SNY icon

HM Payson & Co’s Sanofi SNY Stock Holding History

HM Payson & Co’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$323K Sell
7,582
-566
-7% -$25.3K ﹤0.01% 369
2026
Q1 		$393K Buy
8,148
+900
+12% +$42K 0.01% 327
2025
Q4 		$351K Hold
7,248
– – 0.01% 344
2025
Q3 		$342K Buy
7,248
+235
+3% +$11.3K ﹤0.01% 349
2025
Q2 		$339K Buy
7,013
+744
+12% +$38K 0.01% 339
2025
Q1 		$348K Buy
6,269
+674
+12% +$36.5K 0.01% 326
2024
Q4 		$270K Hold
5,595
– – ﹤0.01% 364
2024
Q3 		$322K Sell
5,595
-969
-15% -$52.3K 0.01% 340
2024
Q2 		$318K Buy
6,564
+644
+11% +$31.1K 0.01% 337
2024
Q1 		$288K Hold
5,920
– – 0.01% 345
2023
Q4 		$294K Sell
5,920
-3,064
-34% -$150K 0.01% 333
2023
Q3 		$482K Buy
8,984
+682
+8% +$36.4K 0.01% 267
2023
Q2 		$447K Sell
8,302
-476
-5% -$25.6K 0.01% 272
2023
Q1 		$478K Buy
8,778
+46
+0.5% +$2.24K 0.01% 254
2022
Q4 		$423K Buy
8,732
+47
+0.5% +$2.06K 0.01% 265
2022
Q3 		$330K Hold
8,685
– – 0.01% 287
2022
Q2 		$435K Hold
8,685
– – 0.01% 259
2022
Q1 		$446K Hold
8,685
– – 0.01% 281
2021
Q4 		$435K Sell
8,685
-1,151
-12% -$56.9K 0.01% 296
2021
Q3 		$474K Sell
9,836
-1,190
-11% -$60.5K 0.01% 281
2021
Q2 		$581K Hold
11,026
– – 0.01% 258
2021
Q1 		$545K Sell
11,026
-1,175
-10% -$56.4K 0.01% 262
2020
Q4 		$593K Buy
12,201
+1,358
+13% +$67K 0.02% 250
2020
Q3 		$544K Buy
10,843
+68
+0.6% +$3.5K 0.02% 241
2020
Q2 		$550K Hold
10,775
– – 0.02% 226
2020
Q1 		$471K Sell
10,775
-10,231
-49% -$490K 0.02% 220
2019
Q4 		$1.05M Sell
21,006
-1,274
-6% -$59.7K 0.03% 204
2019
Q3 		$1.03M Sell
22,280
-6,210
-22% -$268K 0.04% 197
2019
Q2 		$1.23M Sell
28,490
-1,000
-3% -$42.5K 0.04% 177
2019
Q1 		$1.31M Buy
+29,490
New +$1.26M 0.05% 160
2018
Q4 		– Sell
-37,740
Closed -$1.69M – 285
2018
Q3 		$1.69M Sell
37,740
-2,710
-7% -$116K 0.08% 141
2018
Q2 		$1.62M Sell
40,450
-6,071
-13% -$239K 0.07% 147
2018
Q1 		$1.86M Sell
46,521
-1,903
-4% -$79.2K 0.08% 145
2017
Q4 		$2.08M Sell
48,424
-3,269
-6% -$151K 0.08% 144
2017
Q3 		$2.57M Sell
51,693
-1,545
-3% -$74.8K 0.11% 131
2017
Q2 		$2.55M Sell
53,238
-2,338
-4% -$112K 0.12% 128
2017
Q1 		$2.52M Sell
55,576
-5,354
-9% -$227K 0.11% 128
2016
Q4 		$2.46M Sell
60,930
-6,080
-9% -$240K 0.12% 125
2016
Q3 		$2.56M Sell
67,010
-14,324
-18% -$575K 0.12% 125
2016
Q2 		$3.4M Sell
81,334
-7,432
-8% -$305K 0.17% 101
2016
Q1 		$3.56M Sell
88,766
-13,734
-13% -$552K 0.19% 101
2015
Q4 		$4.37M Sell
102,500
-8,296
-7% -$382K 0.22% 94
2015
Q3 		$5.26M Sell
110,796
-21,628
-16% -$1.1M 0.29% 79
2015
Q2 		$6.56M Sell
132,424
-68,561
-34% -$3.47M 0.33% 79
2015
Q1 		$9.94M Sell
200,985
-50,893
-20% -$2.43M 0.5% 62
2014
Q4 		$11.5M Sell
251,878
-16,457
-6% -$799K 0.57% 53
2014
Q3 		$15.1M Buy
268,335
+8,044
+3% +$432K 0.78% 39
2014
Q2 		$13.8M Buy
260,291
+5,654
+2% +$300K 0.71% 41
2014
Q1 		$13.3M Buy
254,637
+27,757
+12% +$1.41M 0.7% 44
2013
Q4 		$12.2M Buy
226,880
+2,183
+1% +$113K 0.65% 49
2013
Q3 		$11.4M Sell
224,697
-34,775
-13% -$1.77M 0.66% 45
2013
Q2 		$13.4M Buy
+259,472
New +$13.8M 0.8% 42

Other funds holding SNY

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
FB
Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
PCM
Palouse Capital Management Spokane, Washington $160M AUM 36.15% 1-Year Est. Return
AAM
Augustine Asset Management Jacksonville, Florida $494M AUM 76.22% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

HM Payson & Co's SNY Position: Q2 2026 in Review

HM Payson & Co reduced its Sanofi (SNY) stake by 6.9% in Q2 2026, selling an estimated $25.3K and leaving 7,582 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

HM Payson & Co first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.1M in Q3 2014. 94 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • HM Payson & Co held 7,582 shares of Sanofi worth $323K as of Q2 2026.
  • HM Payson & Co sold 566 Sanofi shares in Q2 2026, an estimated $25.3K.
  • Sanofi made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #369 holding.
  • HM Payson & Co first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • HM Payson & Co's Sanofi position peaked at $15.1M in Q3 2014.
  • 94 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.